These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 17987346

  • 1. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [Abstract] [Full Text] [Related]

  • 2. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI, Rutkowski P, Michej W.
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [Abstract] [Full Text] [Related]

  • 3. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
    Berger AC, Fierro M, Kairys JC, Berd D, Sato T, Andrel J, Hyslop T, Mastrangelo MJ.
    J Surg Oncol; 2012 Jan; 105(1):15-20. PubMed ID: 21815149
    [Abstract] [Full Text] [Related]

  • 4. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [Abstract] [Full Text] [Related]

  • 5. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN.
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [Abstract] [Full Text] [Related]

  • 6. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [Abstract] [Full Text] [Related]

  • 7. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 8. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 9. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
    Scoggins CR, Bowen AL, Martin RC, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, Hagendoorn L, McMasters KM.
    Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA, Wong SL, Johnson TM, Lowe L, Chang AE, Cimmino VM, Bradford CR, Rees RS, Sabel MS.
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [Abstract] [Full Text] [Related]

  • 11. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S, Sagowski C, Neuber K, Kehrl W, Metternich FU.
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [Abstract] [Full Text] [Related]

  • 12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2005 Aug 13; 149(33):1845-51. PubMed ID: 16128183
    [Abstract] [Full Text] [Related]

  • 13. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian CK, Chang AE, Cimmino VM, Bradford CR, Rees RS, Johnson TM, Sabel MS.
    Ann Surg Oncol; 2008 Sep 13; 15(9):2403-11. PubMed ID: 18626721
    [Abstract] [Full Text] [Related]

  • 14. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, Pilati P, Lise M, Nitti D, Rizzo E, Montesco MC.
    Ann Surg Oncol; 2008 Apr 13; 15(4):1202-10. PubMed ID: 18165880
    [Abstract] [Full Text] [Related]

  • 15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 13; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 16. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA.
    Head Neck; 2002 May 13; 24(5):417-22. PubMed ID: 12001070
    [Abstract] [Full Text] [Related]

  • 17. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.
    Ann Surg Oncol; 2007 May 13; 14(5):1604-11. PubMed ID: 17333418
    [Abstract] [Full Text] [Related]

  • 18. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.
    Br J Dermatol; 2007 Jul 13; 157(1):58-67. PubMed ID: 17501957
    [Abstract] [Full Text] [Related]

  • 19. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.
    Galliot-Repkat C, Cailliod R, Trost O, Danino A, Collet E, Lambert D, Vabres P, Dalac S.
    Eur J Surg Oncol; 2006 Sep 13; 32(7):790-4. PubMed ID: 16822643
    [Abstract] [Full Text] [Related]

  • 20. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S, Metternich FU, Sagowski C, Neuber K, Kehrl W.
    Laryngorhinootologie; 2001 Jun 13; 80(6):313-7. PubMed ID: 11475610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.